C155H172N20O19S3 — CID 158804490
N-cyclohexyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methyl-5-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-pyridin-4-ylbenzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[[4-(1H-pyrazol-4-yl)benzoyl]amino]ethyl]benzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;sulfane (PubChem CID 158804490) has the molecular formula C155H172N20O19S3 and a molecular weight of 2715.40 g/mol. Its IUPAC name is N-cyclohexyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methyl-5-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-pyridin-4-ylbenzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[[4-(1H-pyrazol-4-yl)benzoyl]amino]ethyl]benzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;sulfane.
| Compound Name | N-cyclohexyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methyl-5-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-pyridin-4-ylbenzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[[4-(1H-pyrazol-4-yl)benzoyl]amino]ethyl]benzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;sulfane |
|---|---|
| PubChem CID | 158804490 |
| Molecular Formula | C155H172N20O19S3 |
| Molecular Weight | 2715.40 g/mol |
| Exact Mass | 2713.23 |
| IUPAC Name | N-cyclohexyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methoxy-4-(1H-pyrazol-4-yl)benzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-2-methyl-5-pyridin-4-ylbenzamide;N-[(1S)-1-[3-(cyclopentylcarbamoyl)phenyl]-2-hydroxyethyl]-3-pyridin-4-ylbenzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[[4-(1H-pyrazol-4-yl)benzoyl]amino]ethyl]benzamide;N-cyclopentyl-3-[(1S)-2-hydroxy-1-[(4-pyridin-4-ylbenzoyl)amino]ethyl]benzamide;sulfane |
| SMILES | COc1cc(-c2cn[nH]c2)ccc1C(=O)N[C@H](CO)c1cccc(C(=O)NC2CCCC2)c1.Cc1ccc(-c2ccncc2)cc1C(=O)N[C@H](CO)c1cccc(C(=O)NC2CCCC2)c1.O=C(NC1CCCC1)c1cccc([C@@H](CO)NC(=O)c2ccc(-c3ccncc3)cc2)c1.O=C(NC1CCCC1)c1cccc([C@@H](CO)NC(=O)c2ccc(-c3cn[nH]c3)cc2)c1.O=C(NC1CCCC1)c1cccc([C@@H](CO)NC(=O)c2cccc(-c3ccncc3)c2)c1.O=C(NC1CCCCC1)c1cccc([C@@H](CO)NC(=O)c2ccc(-c3ccncc3)cc2)c1.S.S.S |
| InChI | InChI=1S/2C27H29N3O3.2C26H27N3O3.C25H28N4O4.C24H26N4O3.3H2S/c1-18-9-10-20(19-11-13-28-14-12-19)16-24(18)27(33)30-25(17-31)21-5-4-6-22(15-21)26(32)29-23-7-2-3-8-23;31-18-25(22-5-4-6-23(17-22)27(33)29-24-7-2-1-3-8-24)30-26(32)21-11-9-19(10-12-21)20-13-15-28-16-14-20;30-17-24(20-6-4-8-22(16-20)25(31)28-23-9-1-2-10-23)29-26(32)21-7-3-5-19(15-21)18-11-13-27-14-12-18;30-17-24(21-4-3-5-22(16-21)26(32)28-23-6-1-2-7-23)29-25(31)20-10-8-18(9-11-20)19-12-14-27-15-13-19;1-33-23-12-16(19-13-26-27-14-19)9-10-21(23)25(32)29-22(15-30)17-5-4-6-18(11-17)24(31)28-20-7-2-3-8-20;29-15-22(18-4-3-5-19(12-18)24(31)27-21-6-1-2-7-21)28-23(30)17-10-8-16(9-11-17)20-13-25-26-14-20;;;/h4-6,9-16,23,25,31H,2-3,7-8,17H2,1H3,(H,29,32)(H,30,33);4-6,9-17,24-25,31H,1-3,7-8,18H2,(H,29,33)(H,30,32);3-8,11-16,23-24,30H,1-2,9-10,17H2,(H,28,31)(H,29,32);3-5,8-16,23-24,30H,1-2,6-7,17H2,(H,28,32)(H,29,31);4-6,9-14,20,22,30H,2-3,7-8,15H2,1H3,(H,26,27)(H,28,31)(H,29,32);3-5,8-14,21-22,29H,1-2,6-7,15H2,(H,25,26)(H,27,31)(H,28,30);3*1H2/t2*25-;2*24-;2*22-;;;/m111111.../s1 |
| InChIKey | ITXBSHCJIJXVOU-GFDPBWFSSA-N |
| XLogP | 23.01 |
| TPSA | 588.73 Ų |
| H-Bond Donors | 20 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 43 |
| Heavy Atoms | 197 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2715.40 |
| LogP ≤ 5 | 23.01 |
| H-Bond Donors ≤ 5 | 20 |
| H-Bond Acceptors ≤ 10 | 25 |